These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Escitalopram in the treatment of impulsive-compulsive internet usage disorder: an open-label trial followed by a double-blind discontinuation phase. Dell'Osso B, Hadley S, Allen A, Baker B, Chaplin WF, Hollander E. J Clin Psychiatry; 2008 Mar; 69(3):452-6. PubMed ID: 18312057 [Abstract] [Full Text] [Related]
5. Escitalopram in the treatment of panic disorder: a randomized, double-blind, placebo-controlled trial. Stahl SM, Gergel I, Li D. J Clin Psychiatry; 2003 Nov; 64(11):1322-7. PubMed ID: 14658946 [Abstract] [Full Text] [Related]
6. Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies. Clayton AH, Croft HA, Horrigan JP, Wightman DS, Krishen A, Richard NE, Modell JG. J Clin Psychiatry; 2006 May; 67(5):736-46. PubMed ID: 16841623 [Abstract] [Full Text] [Related]
8. A double-blind, randomized, parallel-group, flexible-dose study to evaluate the tolerability, efficacy and effects of treatment discontinuation with escitalopram and paroxetine in patients with major depressive disorder. Baldwin DS, Cooper JA, Huusom AK, Hindmarch I. Int Clin Psychopharmacol; 2006 May; 21(3):159-69. PubMed ID: 16528138 [Abstract] [Full Text] [Related]
11. [Efficacy and tolerability of escitalopram in anxiety disorders: a review]. Pelissolo A. Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243 [Abstract] [Full Text] [Related]
12. Escitalopram maintenance treatment for prevention of recurrent depression: a randomized, placebo-controlled trial. Kornstein SG, Bose A, Li D, Saikali KG, Gandhi C. J Clin Psychiatry; 2006 Nov; 67(11):1767-75. PubMed ID: 17196058 [Abstract] [Full Text] [Related]
15. Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder. Pollack M, Kinrys G, Krystal A, McCall WV, Roth T, Schaefer K, Rubens R, Roach J, Huang H, Krishnan R. Arch Gen Psychiatry; 2008 May; 65(5):551-62. PubMed ID: 18458207 [Abstract] [Full Text] [Related]
16. Treatment of generalized anxiety disorder with escitalopram: pooled results from double-blind, placebo-controlled trials. Goodman WK, Bose A, Wang Q. J Affect Disord; 2005 Aug; 87(2-3):161-7. PubMed ID: 15982747 [Abstract] [Full Text] [Related]
17. Escitalopram versus sertraline in the treatment of major depressive disorder: a randomized clinical trial. Ventura D, Armstrong EP, Skrepnek GH, Haim Erder M. Curr Med Res Opin; 2007 Feb; 23(2):245-50. PubMed ID: 17288677 [Abstract] [Full Text] [Related]
18. Safety and efficacy of escitalopram in the long-term treatment of generalized anxiety disorder. Davidson JR, Bose A, Wang Q. J Clin Psychiatry; 2005 Nov; 66(11):1441-6. PubMed ID: 16420082 [Abstract] [Full Text] [Related]
19. A double-blind comparison of escitalopram and venlafaxine extended release in the treatment of major depressive disorder. Bielski RJ, Ventura D, Chang CC. J Clin Psychiatry; 2004 Sep; 65(9):1190-6. PubMed ID: 15367045 [Abstract] [Full Text] [Related]
20. Escitalopram in specific phobia: results of a placebo-controlled pilot trial. Alamy S, Wei Zhang, Varia I, Davidson JR, Connor KM. J Psychopharmacol; 2008 Mar; 22(2):157-61. PubMed ID: 18208904 [Abstract] [Full Text] [Related] Page: [Next] [New Search]